VCP
TMO icon

Verus Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Verus Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-437
Closed -$271K – 389
2024
Q3 		$271K Buy
437
+13
+3% +$7.7K 0.03% 285
2024
Q2 		$235K Buy
424
+24
+6% +$13.7K 0.02% 299
2024
Q1 		$232K Buy
+400
New +$224K 0.03% 314
2020
Q1 		$242K Buy
855
+1
+0.1% +$315 0.08% 161
2019
Q4 		$278K Buy
+854
New +$259K 0.09% 180

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Verus Capital Partners's TMO Position: Q4 2024 in Review

Verus Capital Partners sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 437 shares — an estimated $271K sold.

Verus Capital Partners first reported a position in TMO in Q4 2019 and held it in 5 quarters. The position peaked at $278K in Q4 2019. 2,616 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Verus Capital Partners reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • Verus Capital Partners sold 437 Thermo Fisher Scientific shares in Q4 2024, an estimated $271K.
  • Verus Capital Partners first reported a position in Thermo Fisher Scientific in Q4 2019 and held it in 5 quarters.
  • Verus Capital Partners's Thermo Fisher Scientific position peaked at $278K in Q4 2019.
  • 2,616 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Verus Capital Partners's 13F filing for Q4 2024, filed 5 Feb 2025.